SPEM1
Spermatid maturation protein 1
Also known as: C17orf83, FLJ40081, SPEM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4L4
- Gene
- SPEM1
- Ensembl
- ENSG00000181323
- Chromosome
- 17
- Canonical length
- 309 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Calyx
OverviewNCBI Gene
Predicted to be involved in flagellated sperm motility and sperm individualization. Predicted to act upstream of or within spermatogenesis. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
309 residues, UniProt reviewed canonical sequence.
>Q8N4L4|SPEM1
1 MAMVERPRPE WASYHNCNSN SCQDLGNSVL LLLGLIICIN ISINIVTLLW SRFRGVLYQV
61 FHDTICEKEA PKSSLLRKQT QPPKKQSSPA VHLRCTMDPV MMTVSPPPAH RHRRRGSPTR
121 CAHCPVAWAP DTDDEKPHQY PAICSYHWDV PEDWEGFQHT QGTWVPWSQD APESPPQTIR
181 FQPTVEERPL KTGIWSELGL RAYVYPVNPP PPSPEAPSHK NGGEGAVPEA EAAQYQPVPA
241 PTLGPAVIPE FSRHRSSGRI VYDARDMRRR LRELTREVEA LSGCYPLASG SSTAEETSKN
301 WVYRSLTGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPEM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- testis: 71 nTPM
- retina: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- late spermatids: 3,332 nCPM
- early spermatids: 390 nCPM
- late primary spermatocytes: 21 nCPM
- sertoli cells: 4.5 nCPM
- leydig cells: 1.6 nCPM
- undifferentiated spermatogonia: 0.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- midbrain: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPEM1 as an antibody target. Whether an autoantibody or antibody against SPEM1 could matter depends on whether native SPEM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPEM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPEM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...